Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PTRH1 Activators

Forskolin, a prominent diterpene, plays a pivotal role in activating adenylate cyclase, thereby raising intracellular cAMP levels. This surge in cAMP can activate protein kinase A (PKA), a key regulator in various signaling pathways, which in turn has the potential to enhance the activity of PTRH1. Subsequently, Ionomycin, a calcium ionophore, increases the concentration of intracellular calcium, a secondary messenger with a profound effect on calcium-dependent kinases. These kinases are integral to cellular signaling and could thus modify PTRH1 activity by affecting the protein's phosphorylation status or its interaction with other cellular constituents. PMA can mimic diacylglycerol (DAG), activating protein kinase C (PKC), which is known to phosphorylate a wide array of target proteins, potentially including PTRH1, thus altering its function or regulatory mechanisms. LY294002, a potent PI3K inhibitor, disrupts AKT signaling; this interference can lead to cellular adjustments that inadvertently increase PTRH1 activity through complex feedback loops or compensatory mechanisms within the cell. PD98059, by inhibiting MEK, impedes the MAPK/ERK pathway, which might result in a compensatory upregulation of PTRH1's activity, showcasing the intricate nature of intracellular signaling and its impact on protein function.

Rapamycin, an mTOR inhibitor, influences protein synthesis and degradation pathways, which could result in increased expression or altered degradation of PTRH1. SB 216763, a GSK-3 inhibitor, prevents the phosphorylation of GSK-3 substrates, potentially leading to an indirect increase in PTRH1 activity. Compounds that modulate gene expression, such as 5-Azacytidine and Trichostatin A, through their respective inhibition of DNA methyltransferases and histone deacetylases, can also lead to an enhanced expression or activity of PTRH1 by remodeling the chromatin structure and altering transcriptional dynamics. Epigallocatechin gallate and Resveratrol are known to have multiple cellular targets and can modulate signaling pathways that intersect with the regulation of PTRH1 activity. 1-Hydroxypyridine-2-thione zinc salt increases the availability of intracellular zinc which can be critical for the functional or structural aspects of proteins like PTRH1.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin, a calcium ionophore, increases intracellular calcium levels, which can activate calcium-dependent protein kinases that modulate PTRH1 activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) acts as a DAG analog, activating protein kinase C (PKC), which can phosphorylate PTRH1 or alter its regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, disrupts AKT signaling, which can lead to compensatory cellular responses that enhance PTRH1 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059, an inhibitor of MEK, can interrupt the MAPK/ERK pathway, resulting in altered regulation that can upregulate PTRH1 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can affect protein synthesis and potentially increase PTRH1 expression or activity.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

SB 216763, a GSK-3 inhibitor, can prevent GSK-3 from phosphorylating its substrates, potentially resulting in enhanced PTRH1 activity.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine, a DNA methyltransferase inhibitor, can alter gene expression patterns, which may lead to increased PTRH1 activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A, a histone deacetylase inhibitor, can change chromatin structure, potentially facilitating increased activity of PTRH1.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate, a polyphenol, can modulate multiple signaling pathways, thereby influencing PTRH1 activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol, a stilbenoid, can alter various cellular processes, which may lead to enhanced activity of PTRH1.